Quantcast
Last updated on May 24, 2013 at 16:48 EDT

Latest Melanoma Stories

2013-02-26 08:30:03

BOULDER, Colo., Feb. 26, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen Annual Health Care Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Event: Cowen Annual Health Care Conference Presenter: Ron Squarer, Chief Executive...

2013-02-26 08:28:10

Thought-Leaders to Steer Development of the Company's ImmunoPulse Program SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the formation of a Melanoma Advisory Board (MAB) for the company's metastatic melanoma program. (Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO) Bringing together a group of...

2013-02-24 16:20:25

OTTAWA, Feb. 24, 2013 /CNW/ - Today, the Honourable Leona Aglukkaq, Minister of Health and MP James Bezan (Selkirk-Interlake, MB), announced that Health Canada intends to strengthen its health warnings about the dangers of tanning beds. "The Harper Government is committed to protecting the health and safety of Canadian families," said Minister Aglukkaq. "Young adults should be concerned about the health risks associated with the use of tanning beds, including skin cancer. Today,...

2013-02-21 08:30:53

IRVINGTON, N.Y., Feb. 21, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA). Despite alarming increases in skin cancer rates in the U.S., only 24% of American adults have had a skin check by a dermatologist. This statistic is one of several important findings from a survey conducted online by Harris Interactive® that reveals insights into behaviors regarding skin cancer detection and illustrates the urgency around improved preventative care. The study was conducted on behalf...

2013-02-20 00:20:46

LOS ANGELES, Feb. 19, 2013 /PRNewswire/ -- On Saturday February 16, 2013, Victor Marx provided information about "All Things Possible" to the celebrity guests of the pre-Oscar event produced by Suzanne DeLaurentiis and John Gentry Tennyson to benefit the Melanoma Research Foundation. Some of the celebrities indulging in the suite included: Niecy Nash, Navid Negahban, Vanessa Bell Calloway, Sheryl Lee Ralph, Daphne Wayans, Shar Jackson, Kaya Jones, Sheree Fletcher, Rebecca Crews, Katie...

2013-02-19 16:24:11

LOS ANGELES, Feb. 19, 2013 /PRNewswire/ -- On Saturday February 16, 2013, Luc Mena Photography made an impressive debut at the pre-Oscar event produced by Suzanne DeLaurentiis and John Gentry Tennyson to benefit the Melanoma Research Foundation. Some of the celebrities indulging in the suite included: Niecy Nash, Navid Negahban, Vanessa Bell Calloway, Sheryl Lee Ralph, Daphne Wayans, Shar Jackson, Kaya Jones, Sheree Fletcher, Rebecca Crews, Katie Cleary, Austin Anderson, Peggy Tanous,...

2013-02-19 16:23:58

LOS ANGELES, Feb. 19, 2013 /PRNewswire/ -- On Saturday February 16, 2013, Jeremy Lucas and Mark Espinosa of Jaxx Theatricals delighted the celebrity guests of the pre-Oscar event produced by Suzanne DeLaurentiis and John Gentry Tennyson to benefit the Melanoma Research Foundation. Some of the celebrities indulging in the suite included: Niecy Nash, Navid Negahban, Vanessa Bell Calloway, Sheryl Lee Ralph, Daphne Wayans, Shar Jackson, Kaya Jones, Sheree Fletcher, Rebecca Crews, Katie...

2013-02-19 11:35:02

Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research published today in the Journal of Experimental Medicine. The scientists discovered that the gene TP63 is unexpectedly expressed in some melanoma and correlates significantly with a worse prognosis. It is hoped this new understanding of what makes some melanoma cells so difficult to kill will help inform the...

2013-02-14 12:25:57

HOUSTON, Feb. 14, 2013 /PRNewswire/ -- Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating...

2013-02-08 20:22:22

BOULDER, Colo., Feb. 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Event: Leerink Swann Healthcare Conference Presenter: Ron Squarer, Chief Executive...